1. Home
  2. SRFM vs CASI Comparison

SRFM vs CASI Comparison

Compare SRFM & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRFM
  • CASI
  • Stock Information
  • Founded
  • SRFM 2011
  • CASI 1991
  • Country
  • SRFM United States
  • CASI China
  • Employees
  • SRFM N/A
  • CASI N/A
  • Industry
  • SRFM Transportation Services
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SRFM Consumer Discretionary
  • CASI Health Care
  • Exchange
  • SRFM Nasdaq
  • CASI Nasdaq
  • Market Cap
  • SRFM 62.8M
  • CASI 58.8M
  • IPO Year
  • SRFM 2023
  • CASI 1996
  • Fundamental
  • Price
  • SRFM $5.61
  • CASI $2.98
  • Analyst Decision
  • SRFM Hold
  • CASI Strong Buy
  • Analyst Count
  • SRFM 2
  • CASI 1
  • Target Price
  • SRFM $3.40
  • CASI $6.00
  • AVG Volume (30 Days)
  • SRFM 762.4K
  • CASI 56.0K
  • Earning Date
  • SRFM 11-14-2024
  • CASI 11-15-2024
  • Dividend Yield
  • SRFM N/A
  • CASI N/A
  • EPS Growth
  • SRFM N/A
  • CASI N/A
  • EPS
  • SRFM N/A
  • CASI N/A
  • Revenue
  • SRFM $118,212,000.00
  • CASI $22,055,000.00
  • Revenue This Year
  • SRFM $102.41
  • CASI N/A
  • Revenue Next Year
  • SRFM $47.46
  • CASI $134.79
  • P/E Ratio
  • SRFM N/A
  • CASI N/A
  • Revenue Growth
  • SRFM 198.78
  • CASI N/A
  • 52 Week Low
  • SRFM $0.90
  • CASI $2.05
  • 52 Week High
  • SRFM $11.48
  • CASI $8.19
  • Technical
  • Relative Strength Index (RSI)
  • SRFM 69.40
  • CASI 38.05
  • Support Level
  • SRFM $2.64
  • CASI $2.50
  • Resistance Level
  • SRFM $3.67
  • CASI $3.47
  • Average True Range (ATR)
  • SRFM 0.82
  • CASI 0.44
  • MACD
  • SRFM 0.12
  • CASI 0.07
  • Stochastic Oscillator
  • SRFM 78.87
  • CASI 32.65

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: